Hypertension in adult polycystic kidney disease: a narrative review
Keyword(s):
Autosomal dominant polycystic kidney disease (ADPKD) is an inherited renal disorder that impacts approximately 12 million worldwide. It is characterized by bilateral kidney enlargement and cystic growth. Hypertension (HTN) is a focal point in the management of ADPKD and is linked to a faster progression to end stage renal disease. Current novel therapies have proven to reduce the progression of renal damage. The ideal goal is to minimize risk through preventative studies and pharmacology to further increase life expectancy and quality. The purpose of this article is to highlight the importance of blood pressure management in ADPKD and review current literature to determine the most effective preventative pharmacotherapy.
Insurance for autosomal dominant polycystic kidney disease patients prior to end-stage renal disease
1996 ◽
Vol 27
(2)
◽
pp. 220-223
◽
2017 ◽
Vol 37
(4)
◽
pp. 384-388
◽
1996 ◽
Vol 11
(supp6)
◽
pp. 21-23
◽
2002 ◽
Vol 39
(3)
◽
pp. 660
◽